generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …

efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in …

-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on … several off-patent molecules before and after the policy reform. Off-patent drugs not subject to RP serve as our control group …

This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a …

This paper investigates the choice of an intellectual protection regime for a process innovation. We set up a multi …-stage model in which choosing between patent and trade secrecy is affected by three parameters: the patent strength defined as the … probability that the right is upheld by the court, the cost of imitating a patented innovation relative to the cost of imitating a …

We analyze the role of imitation and innovation in promoting technological progress in new members of European Union …: the Czech Republic, Hungary, Poland and Slovakia. The two modes of technological development - innovation and imitation … - are distinguished from one another by identifying the dominant orientation of innovation efforts at the industry level …

We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R … advertising, we show that such overinvestment incentives are always present, and that more generous patent protection implies that … a larger share of the patent rent is spent on marketing, relative to R&D …

I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …-2006. The estimates imply that chemotherapy innovation accounted for at least one-sixth of the decline in French cancer …